{
    "organizations": [],
    "uuid": "1b71b167c57237e5657bfa57f235fec2374b25d8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-qiagen-signs-agreement-to-acquire/brief-qiagen-signs-agreement-to-acquire-stat-dx-idUSASB0C3C2",
    "ord_in_thread": 0,
    "title": "BRIEF-Qiagen Signs Agreement To Acquire Stat-Dx",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - Qiagen Nv:\n* QIAGEN ENTERS INTO AGREEMENT TO ACQUIRE STAT-DX, PLANS TO LAUNCH A NEXT-GENERATION, FULLY INTEGRATED MULTIPLEX PLATFORM FOR SYNDROMIC DISEASE TESTING\n* QIAGEN NV - NEW SYSTEM LAUNCH PLANNED FOR H2 2018 WITH TWO CE-IVD MOLECULAR DIAGNOSTICS, U.S. LAUNCH PLANNED FOR 2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-01T05:24:00.000+02:00",
    "crawled": "2018-02-01T14:57:22.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "qiagen",
        "nv",
        "qiagen",
        "enters",
        "agreement",
        "acquire",
        "plan",
        "launch",
        "fully",
        "integrated",
        "multiplex",
        "platform",
        "syndromic",
        "disease",
        "testing",
        "qiagen",
        "nv",
        "new",
        "system",
        "launch",
        "planned",
        "h2",
        "two",
        "molecular",
        "diagnostics",
        "launch",
        "planned",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}